Thus, if we combine these data with the reduction in mtKRAS CRC cell viability after the silencing of PXR and treatment with Irinotecan, we conclude that autophagy could act as a protective mechanism through PXR induction for mtKRAS CRC cell lines against this chemotherapeutic agent. The gene discussed is NR1I2; the disease is colorectal carcinoma.